Skip to main content

Maple Grove Voice

What are the Five Main Infusions Derived Collected Plasma? (Sponsored)

Nov 28, 2016 05:18PM ● By BioLife Plasma Services
The following information was provided and sponsored by BioLife Plasma Services - Maple Grove

The plasma collected at BioLife Plasma Services is processed into a wide variety of life-saving therapeutics that benefit thousands of people everyday. Five main infusions are derived from the plasma:

Hemophilia is a genetic bleeding disorder that prevents blood from forming an effective clot. A disorder that primarily affects males, people living with hemophilia do not have enough of, or are missing, one of the blood clotting proteins naturally found in blood. Individuals with hemophilia A (also called classic hemophilia) lack a sufficient amount of a protein called clotting factor VIII,
while individuals with hemophilia B (also called Christmas disease) lack a sufficient amount of clotting factor IX.

The plasma donated at BioLife Plasma Services is processed into replacement infusions -- HEMOFIL M (Factor VIII), FEIBA NF Anti-Inhibitor Coagulant Complex and BEBULIN (Factor IX Complex). These infusions are infused intravenously to temporarily replace a missing or
nonfunctioning factor in people living with hemophilia. These plasma-based factor concentrates help individuals who suffer from hemophilia lead more active and healthy

A loss of blood volume affects patients in a variety of trauma conditions. Restoration of this lost blood is often a key factor in emergency situations with a long-term favorable outcome.
The therapeutic protein albumin, derived from plasma donated at BioLife Plasma Services, is used in hospitals across the United States to treat trauma and burn victims, as well as patients suffering from shock. BUMINATE is albumin packaged in glass bottles and FLEXBUMIN is albumin packaged in a flexible container.

Once classified as fatal disorders, more than 80 primary immune deficiency disorders affect approximately 500,000 people in the United States. These disorders occur when a part of the body’s immune system is missing or does not function properly. Today, advances in medicine and our understanding of these deficiencies have resulted in the development of immunoglobulins (antibodies) that assist the patient’s immune system in fighting off infection.
Gammagard is a therapeutic derived from plasma donated at BioLife Plasma Services for use in primary immune deficiencies, as well as B-cell Chronic Lymphocytic Leukemia and Idiopathic Thrombocytopenic Purpura.

People with alpha1-antitrypsin deficiency are born with a lack or low levels of a blood protein
called AAT. This protein helps protect lung tissue from damage from enzymes that are released by white blood cells. This condition may result in serious lung disease, resulting in emphysema. Chronic augmentation infusion, ARALAST and GLASSIA, derived from plasma donated at BioLife Plasma Services are used to treat patients with congenital deficiency of alpha1-antitrypsin with clinically evident emphysema.

During surgery, the ability to control bleeding quickly helps reduce complications and improve
a patient’s outcome. Increasingly, surgeons are turning to a solution called fibrin sealant,
comprised of human fibrinogen and human thrombin, two components derived from plasma
donated at BioLife Plasma Services. Fibrin sealant is used to replicate the natural blood
clotting process to stop bleeding in a variety of surgical procedures.

If you're interested in becoming a donor, visit the BioLife Plasma Services website here or call 763-416-5511

Like what you're reading? Subscribe to the Maple Grove Voice free newsletter to catch every headline